List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 32 studies with search of:   Belarus
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Recruiting Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-Dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: SSR126517E "biotinylated idraparinux";   Drug: warfarin
22 Recruiting Clinical Study Assessing SSR126517E Injections Once-Weekly in Pulmonary Embolism Therapeutic Approach
Conditions: Embolism;   Thrombosis
Interventions: Drug: SSR126517E;   Drug: warfarin
23 Recruiting Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
Condition: Acromegaly
Interventions: Drug: C2L-OCT-01 PR, 10 or 20 mg;   Drug: C2L-OCT-01 PR, 20 mg
24 Completed Study of 3 Doses of ARD-0403 in Testosterone Deficient Men
Condition: Hypogonadism
Intervention: Drug: ARD-0403
25 Completed Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients
Condition: Acromegaly
Interventions: Drug: C2L-OCT-01 PR, 30 mg;   Drug: Octreotide acetate prolonged release, 30 mg
26 Active, not recruiting A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-Valvular Atrial Fibrillation
Conditions: Atrial Fibrillation;   Thromboembolism
Interventions: Drug: Du-176b;   Drug: DU-176b;   Drug: DU-176b;   Drug: DU-176b;   Drug: warfarin
27 Recruiting Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions
Condition: Peripheral Vascular Diseases
Interventions: Drug: XRP0038/NV1FGF;   Drug: placebo
28 Recruiting Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
Condition: Acromegaly
Intervention: Drug: C2L-OCT-01 PR 30 mg
29 Completed Solifenacin Succinate Versus Tolterodine 4mg Once Daily
Condition: Urinary Bladder, Overactive
Interventions: Drug: Solifenacin succinate;   Drug: Tolterodine
30 Recruiting International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks
Condition: Environment
Intervention:
31 Active, not recruiting The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: insulin glargine (HOE901);   Drug: omega-3 fatty acids;   Drug: placebo
32 Completed Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)
Conditions: Myocardial Infarction;   Acute ST-Segment Elevation
Intervention: Drug: Enoxaparin sodium (XRP4563)

Previous Page (1-20) Studies Shown (21-32) Next Page
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services